Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2, indicating administrative updates to the site’s footer and history entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:32:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.2.0 to v3.3.2. No changes to study data, layouts, or navigation were observed.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The government funding and operating status notice was removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:11:26.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The new screenshot shows a visual refresh of the Record History page with the same version entries and layout as the old screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T09:53:00.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    - Added a government funding status notice and operating details for the NIH Clinical Center, indicating possible delays and updated status references. - Updated software version from v3.1.0 to v3.2.0.
    Difference
    9%
    Check dated 2025-10-05T14:18:38.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T09:44:23.000Z thumbnail image

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.